TOPIRAMATE
Generic: TOPIRAMATE
Aurobindo Pharma LimitedManufacturer
ORALRoute
TOPIRAMATEActive Substance
2023-09-27Original Approval
TOPIRAMATE is FDA application ANDA215449, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2014-09-15
TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India DistributPresence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Class III2021-10-25
Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Discoloration
Class III2013-04-05
Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics LtChemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - o
Top Reported Reactions
1
DRUG INEFFECTIVE
7,043 reports
2
OFF LABEL USE
5,695 reports
3
HEADACHE
3,683 reports
4
NAUSEA
3,328 reports
5
FATIGUE
3,197 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
2,623 reports
7
PAIN
2,574 reports
8
MIGRAINE
2,545 reports
9
DIZZINESS
2,421 reports
10
SEIZURE
2,273 reports